Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 497781 - 497800 out of 558234 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Sweden | (L04AC07) tocilizumab | RoActemra® | 20, 20 mg/ml , Injektionsflaska, 1 x 20 ml (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | AbacusMedicineA/S |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 4, 20 mg/ml , Injektionsflaska, 1 x 4 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 20, 20 mg/ml , Injektionsflaska, 1 x 20 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 10, 20 mg/ml , Injektionsflaska, 1 x 10 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 10, 20 mg/ml , Injektionsflaska, 1 x 10 ml (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | OrifarmAB |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 4, 20 mg/ml , Injektionsflaska, 1 x 4 ml (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | OrifarmAB |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 20, 20 mg/ml , Injektionsflaska, 1 x 20 ml (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | OrifarmAB |
| Sweden | (L04AC07) tocilizumab | Tyenne | 4, 20 mg/ml , Injektionsflaska, 1 x 4 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | FreseniusKabiAB |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 40, 20 mg/ml , Injektionsflaska, 4 x 10 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 80, 20 mg/ml , Injektionsflaska, 4 x 20 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 80, 20 mg/ml , Injektionsflaska, 4 x 20 ml (PD Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | OrifarmAB |
| Sweden | (L04AC07) tocilizumab | RoActemra® | 16, 20 mg/ml , Injektionsflaska, 4 x 4 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab | RoActemra | 4, 162 mg , Förfylld spruta, 4 x 1 st | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheAB |
| Sweden | (L04AC07) tocilizumab | RoActemra | 4, 162 mg , Förfylld spruta, 4 x 1 st (PD Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | AbacusMedicineA/S |
| Sweden | (L04AC07) tocilizumab | RoActemra | 4, 162 mg , Förfylld injektionspenna, 4 x 1 st | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid; Cytokine Release Syndrome; Giant Cell Arteritis; COVID-19 virus infection | RocheAB |
| Sweden | (L04AC12) brodalumab | Kyntheum | 2, 210 mg , Förfylld spruta, 2 st | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis | LEOPharmaAB |
| Sweden | (L04AC13) ixecizumab | Taltz | 1, 80 mg , Förfylld spruta, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis | EliLillySwedenAB |
| Sweden | (L04AC13) ixecizumab | Taltz | 1, 80 mg , Förfylld injektionspenna, 1 st (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Psoriasis | ParanovaLäkemedelAB |
| Sweden | (L04AC14) sarilumab | Kevzara | 2, 150 mg , Förfylld injektionspenna, 2 st | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAB |
| Sweden | (L04AC14) sarilumab | Kevzara | 2, 200 mg , Förfylld injektionspenna, 2 st | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | SanofiAB |
Pages
